BioLife Price To Sales Ratio from 2010 to 2024
| BLFS Stock | USD 26.01 0.62 2.44% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 4.95869196 | Current Value 4.71 | Quarterly Volatility 479.53808794 |
Check BioLife Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLife Solutions' main balance sheet or income statement drivers, such as Interest Expense of 1.9 M, Selling General Administrative of 52.9 M or Total Revenue of 150.4 M, as well as many indicators such as Price To Sales Ratio of 4.71, Dividend Yield of 0.0014 or PTB Ratio of 2.0. BioLife financial statements analysis is a perfect complement when working with BioLife Solutions Valuation or Volatility modules.
BioLife | Price To Sales Ratio |
Latest BioLife Solutions' Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of BioLife Solutions over the last few years. Price to Sales Ratio is figured by comparing BioLife Solutions stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on BioLife Solutions sales, a figure that is much harder to manipulate than other BioLife Solutions multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. BioLife Solutions' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioLife Solutions' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 8.01 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
BioLife Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 130.77 | |
| Geometric Mean | 8.00 | |
| Coefficient Of Variation | 366.70 | |
| Mean Deviation | 231.11 | |
| Median | 4.78 | |
| Standard Deviation | 479.54 | |
| Sample Variance | 229,957 | |
| Range | 1.9K | |
| R-Value | (0.43) | |
| Mean Square Error | 202,071 | |
| R-Squared | 0.18 | |
| Significance | 0.11 | |
| Slope | (46.00) | |
| Total Sum of Squares | 3.2M |
BioLife Price To Sales Ratio History
About BioLife Solutions Financial Statements
BioLife Solutions shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although BioLife Solutions investors may analyze each financial statement separately, they are all interrelated. The changes in BioLife Solutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on BioLife Solutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 4.96 | 4.71 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.